Back to Research & Science
Research & Science••8 min read

KLOW Peptide Dosage & Frequency Chart

Searching for a KLOW peptide dosage and frequency chart? Here's the blend math by label, how frequency discussions online differ from evidence, and how to log a four-component vial — without dosing advice.

PeptIQ Research Team
Editorial
KLOW Peptide Dosage & Frequency Chart

PeptIQ app

Track your peptide protocols in PeptIQ

Log injections, vial supply, and reminders. Use peptiq.io calculators when you need math on the web.

Get the appOpen web app

iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

KLOW Dosage Chart, Explained

People searching "klow peptide dosage and frequency chart" or "klow peptide dose per day" usually want two things: how much of each component is in a draw, and how often anyone pins it. This companion to our KLOW peptide blend guide focuses on that chart math.

KLOW is a four-peptide blend typically sold as BPC-157 + TB-500 + GHK-Cu + KPV in one vial (GLOW plus KPV). There is no randomized clinical trial of "KLOW" as a product, and none of the four components is FDA-approved for injection. Charts online are label arithmetic plus forum cadence — not a protocol.

This article is educational only. It does not recommend doses or schedules. Talk with a licensed clinician before using any peptide.

What's in KLOW (Investigational Components)

ComponentWhat it isResearch context (not approval)
BPC-157Synthetic 15-amino-acid peptide from a gastric sequenceMostly animal musculoskeletal and gut models; a 2025 narrative review found only three small human pilot studies
TB-500Synthetic fragment marketed as related to thymosin β4Parent Tβ4 has regenerative literature; the fragment itself lacks strong human exposure data
GHK-CuNaturally occurring copper-binding tripeptideSkin, wound and gene-expression research; much of it lab, animal or topical
KPVLys-Pro-Val tripeptideAnti-inflammatory effects in cell and mouse colitis models via PepT1 uptake

Ratios vary by seller. Always work from your own vial's Certificate of Analysis / label milligrams, not a screenshot from a forum.

FDA has separately flagged compounded BPC-157, injectable GHK-Cu, KPV, and TB-500 (thymosin β4 fragment) among bulk substances with significant safety-information gaps or immunogenicity concerns for compounding — that is not product approval.

KLOW Dosage Chart: Per-Draw Blend Math

A blend cannot be split. Every draw contains all four peptides in the label's fixed ratio. For a U-100 insulin syringe, 10 units = 0.1 mL.

mg of one component per 10 units = (mg of that component on the label ÷ mL of water added) × 0.1

Example label A (common "heavy GHK" style write-ups)

BPC-157 10 mg + TB-500 10 mg + GHK-Cu 50 mg + KPV 10 mg (80 mg total)

Water addedBPC-157 / 10 unitsTB-500 / 10 unitsGHK-Cu / 10 unitsKPV / 10 units
2 mL0.5 mg0.5 mg2.5 mg0.5 mg
3 mL0.333 mg0.333 mg1.667 mg0.333 mg
5 mL0.2 mg0.2 mg1.0 mg0.2 mg

Example label B (even-ish four-way, 40 mg total)

10 mg of each component

Water addedEach component / 10 units
2 mL0.5 mg
3 mL0.333 mg
5 mL0.2 mg

Same "10 units," very different absolute amounts if the label ratio changes. That is why klow dosage chart screenshots conflict online.

These tables are arithmetic only. They are not a recommended milligram target. Use the web KLOW blend reconstitution calculator with your label numbers.

Frequency Patterns People Discuss (Not Evidence)

There is no literature-backed "KLOW frequency chart." Component half-life stories conflict (shorter-acting peptides discussed as more frequent; TB-500 stories often less frequent). Stuffing four stories into one syringe does not reconcile them.

What shows up in community write-ups (uncontrolled habit, not a trial arm):

Context people nameCadence they repeatHonest reading
Acute recovery storySeveral days per week, sometimes dailyUncontrolled habit
Maintenance story2–3 days per weekUncontrolled habit
Cycle-length storyMulti-week blocks, then time offForum calendar

So "klow peptide dose per day" has no clinical answer. If a clinician is supervising you, frequency belongs in their plan, logged against your vial math — not copied from a chart.

KLOW vs GLOW vs Wolverine

BlendBPC-157TB-500GHK-CuKPV
Wolverine✓✓
GLOW✓✓✓
KLOW✓✓✓✓

Adding peptides adds variables. If you react to a blend, you cannot tell which component caused it without splitting vials under clinician guidance.

Why Separate Vials Sometimes Beat the Cake

Educational reasons people split (not recommendations):

  • Different goals need different ratios — a fixed cake locks every draw.
  • Adverse effects can't be isolated — edema stories often get blamed on TB-500 in forums; a blend won't let you pause one component cleanly.
  • Tracking clarity — stacks next to GLP-1s or other protocols get noisier when four agents move together.

Track This in PeptIQ

If a licensed clinician is guiding a blend, log it as one vial with four named components so each draw shows how much of each peptide you actually used. PeptIQ supports multi-component vials, injection-site rotation and check-ins for joints, gut comfort and skin notes. Do reconstitution math on the web KLOW calculator, then track adherence in the app. (Web calculator pages are separate from the iOS app surface.)

Frequently Asked Questions

Q: What is a KLOW peptide dosage and frequency chart?

A: Usually a table of milligrams-per-draw by water volume, plus a forum cadence. The math can be correct for a given label; the frequency column is not evidence-based for the blend.

Q: What is the KLOW peptide dose per day?

A: There is no clinically established daily dose for KLOW. No trials have tested the four-peptide product. Dosing decisions belong with a licensed clinician using your actual label.

Q: Why do KLOW dosage charts online disagree?

A: Labels differ. A GHK-heavy 80 mg vial and an even 40 mg vial give very different amounts per unit at the same water volume.

Q: Is KLOW FDA-approved?

A: No. The blend is not approved, and the individual components are not FDA-approved injectable drugs. FDA has published compounding safety concerns for several of them.

Q: How is KLOW different from GLOW?

A: KLOW adds KPV to the GLOW trio (BPC-157, TB-500, GHK-Cu).

Sources

This article is educational content from PeptIQ. It is not medical advice. Talk with a licensed clinician before starting, stopping, or changing any peptide, medication, or injection practice.

Related topics

Share this article

Track Your Peptide Protocols

Use PeptIQ to log injections and vial supply, use peptiq.io calculators for math on the web, and keep protocols organized.

Stay ahead of the peptide conversation

Weekly-ish notes on new research, wiki trends, and practical tracking tips. No spam — unsubscribe anytime.

Educational updates only — not medical advice. Privacy